UK-US Deal Boosts NHS, Critics Warn of Costs
UK News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
UK Secures Drug Export Deal, Boosts NHS Spending: A Controversial Move
The UK struck a deal with the US to protect its drug exports from Trumps tariffs, potentially saving up to £5 billion annually. In return, the NHS gains flexibility to pay more for select treatments, aiming to extend lives for serious patients. NICE raised its spending threshold, fast-tracking approvals for two cancer drugs. Government officials, pharma leaders, and patient groups celebrate job safeguards and research boosts, but critics warn of potential cost overruns and foreign influence on NHS priorities.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/fa919cdb93390eeb